Lower urinary tract symptoms are common after nerve damage and a new review summarizes the treatment forms and reasons behind it in patients with Parkinson disease. One of the treatment options available is intermittent catheterization.
Intermittent catheterization revolutionized the management of the neurogenic bladder in the late 1970s, in many cases replacing the need for surgery. Throughout the years, the therapy and the catheters have evolved and there is newly published research supporting the cost-effectiveness of hydrophilic coated catheters for intermittent catheterization.
You will find a summary from these articles in this blog post!
http://www.jurology.com/article/S0022-5347(16)31867-5/fulltext
Bloom DA. US.
Editorial describing the introduction of clean intermittent catheterization into clinical practice.
Introducing intermittent catheterization for use by patients in their home setting was groundbreaking in the late 1970s, replacing urinary diversion as the routine approach to managing the neuropathic bladder.
The Journal of Urology sheds new light on when intermittent catheterization was introduced as a general practice therapy in the 1970s.
https://bmcurol.biomedcentral.com/articles/10.1186/s12894-016-0191-1
Rognoni C, Tarricone R. Italy.
Review comparing hydrophilic to non-hydrophilic coated catheters for intermittent catheterization.
Hydrophilic coated catheters for intermittent catheterization were found to reduce the risk of urinary tract infection (UTI).
Meta-analysis verifying previous findings of UTI risk reduction associated with use of hydrophilic-coated catheters for intermittent catheterization. (Further described in the highlight section. Open access.)
https://www.ncbi.nlm.nih.gov/pubmed/27958390
Ogawa T, Sakakibara R, Kuno S, Ishizuka O, Kitta T, Yoshimura N. Japan.
Review of lower urinary tract symptoms (LUTS) and their treatment in Parkinson disease or multiple system atrophy.
Patients with Parkinson disease or multiple system atrophy often have LUTS related to overactive bladder and voiding difficulties. Exact prevalence in Parkinson disease is not established but was reported to vary between 27 and 70%.
Review summarizing the need for treatment of LUTS in patients with Parkinson disease or multiple system atrophy. Anticholinergics and intermittent catheterization are among the treatment options.
This blog post is an extract from the Science Alert from January 2017 (76040-USX-1701)